Literature DB >> 3099780

Purification of human procollagen type III N-proteinase from placenta and preparation of antiserum.

R Halila, L Peltonen.   

Abstract

Procollagen type III N-proteinase, of Mr about 70,000, was detected in human placental tissue and purified from this source more than 5800-fold. It was found to be a glycoprotein, which was bound to both concanavalin A-Ultrogel and heparin-Sepharose affinity columns. Binding to a type III pN-collagen-Sepharose affinity column was used as the final step in purification. The purified enzyme accepted only native type III procollagen or [14C]carboxymethylated type III pN-collagen as its substrate; type I, type II and type IV procollagen and heat-denatured type III pN-collagen were not cleaved by the enzyme. Antibodies against this purified enzyme protein raised in rabbits demonstrated a high inhibitory effect on the enzyme activity. Immunoblotting of the denatured protein and immunoelectrophoresis of the native enzyme showed only one major antigenic component, again with an Mr of about 70,000. The antibodies cross-reacted with the enzyme preparation from foetal-calf aorta smooth-muscle cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3099780      PMCID: PMC1147237          DOI: 10.1042/bj2390047

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

3.  Time lag in the secretion of collagen by matrix-free tendon cells and inhibition of the secretory process by colchicine and vinblastine.

Authors:  P Dehm; D J Prockop
Journal:  Biochim Biophys Acta       Date:  1972-04-21

4.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

5.  Production of procollagen by human fibroblasts in culture.

Authors:  B D Smith; P H Byers; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

6.  Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome.

Authors:  J R Lichtenstein; G R Martin; L D Kohn; P H Byers; V A McKusick
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

7.  Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins.

Authors:  H Hjelm; K Hjelm; J Sjöquist
Journal:  FEBS Lett       Date:  1972-11-15       Impact factor: 4.124

8.  Polypeptides of the tail fibres of bacteriophage T4.

Authors:  J King; U K Laemmli
Journal:  J Mol Biol       Date:  1971-12-28       Impact factor: 5.469

9.  Collagen made of extended -chains, procollagen, in genetically-defective dermatosparaxic calves.

Authors:  A Lenaers; M Ansay; B V Nusgens; C M Lapière
Journal:  Eur J Biochem       Date:  1971-12-10

10.  A sensitive and rapid method for assaying the activity of type III procollagen amino-terminal proteinase.

Authors:  R Halila
Journal:  Anal Biochem       Date:  1985-02-15       Impact factor: 3.365

View more
  6 in total

1.  c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid.

Authors:  G J Fisher; S Datta; Z Wang; X Y Li; T Quan; J H Chung; S Kang; J J Voorhees
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.

Authors:  A J Richards; J C Lloyd; P Narcisi; P N Ward; A C Nicholls; A De Paepe; F M Pope
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

3.  Structure of cDNA clones coding for human type II procollagen. The alpha 1(II) chain is more similar to the alpha 1(I) chain than two other alpha chains of fibrillar collagens.

Authors:  C T Baldwin; A M Reginato; C Smith; S A Jimenez; D J Prockop
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

4.  The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.

Authors:  K Hørslev-Petersen; T Saxne; D Haar; B S Thomsen; K D Bentsen; P Junker; I Lorenzen
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  The collαgen III fibril has a "flexi-rod" structure of flexible sequences interspersed with rigid bioactive domains including two with hemostatic roles.

Authors:  J Des Parkin; James D San Antonio; Anton V Persikov; Hayat Dagher; Raymond Dalgleish; Shane T Jensen; Xavier Jeunemaitre; Judy Savige
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

6.  Type V collagen: molecular structure and fibrillar organization of the chicken alpha 1(V) NH2-terminal domain, a putative regulator of corneal fibrillogenesis.

Authors:  T F Linsenmayer; E Gibney; F Igoe; M K Gordon; J M Fitch; L I Fessler; D E Birk
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.